Auna (NYSE:AUNA – Get Free Report) was upgraded by Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Saturday, Wall Street Zen reports.
Separately, Weiss Ratings restated a “sell (d)” rating on shares of Auna in a report on Monday, September 21st. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $6.97.
View Our Latest Analysis on Auna
Auna Stock Down 0.1%
Shares of NYSE:AUNA opened at $5.16 on Friday. Auna has a 1 year low of $4.09 and a 1 year high of $6.30. The company has a debt-to-equity ratio of 1.61, a current ratio of 1.08 and a quick ratio of 1.00. The business’s 50-day moving average is $5.21 and its 200-day moving average is $5.11. The company has a market capitalization of $381.52 million, a price-to-earnings ratio of 73.65 and a beta of 0.62.
Auna (NYSE:AUNA – Get Free Report) last released its earnings results on Friday, August 14th. The company reported $0.15 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.11). The business had revenue of $362.85 million for the quarter, compared to analyst estimates of $357.39 million. Auna had a return on equity of 12.88% and a net margin of 0.44%. Equities research analysts predict that Auna will post 0.79 earnings per share for the current year.
Institutional Investors Weigh In On Auna
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Renaissance Technologies LLC boosted its position in shares of Auna by 487.7% during the 1st quarter. Renaissance Technologies LLC now owns 668,457 shares of the company’s stock worth $3,683,000 after purchasing an additional 554,707 shares in the last quarter. Lazard Asset Management LLC acquired a new stake in shares of Auna in the 1st quarter valued at about $557,000. Hsbc Holdings PLC acquired a new stake in shares of Auna in the 1st quarter valued at about $324,000. Arrowstreet Capital Limited Partnership bought a new stake in Auna in the 1st quarter valued at about $316,000. Finally, Squarepoint Ops LLC acquired a new position in Auna during the 2nd quarter worth approximately $149,000.
Auna News Roundup
Here are the key news stories impacting Auna this week:
- Positive Sentiment: Auna reaffirmed its full-year 2026 revenue-growth guidance, supported by favorable third-quarter patient volumes and specialty-service trends. The company also cited signs of recovery in Mexico, which may help offset pressure elsewhere. Auna Announces Preliminary Update to Full-Year 2026 Outlook
- Positive Sentiment: The company said all conditions precedent have been fulfilled for construction of the Centro Ambulatorio Trecca in Peru under its public-private partnership with EsSalud. The milestone reduces execution uncertainty and advances a potentially important long-term growth project. Centro Ambulatorio Trecca Conditions Precedent
- Positive Sentiment: Auna’s analyst and investor day provided additional investor visibility into its strategy, operating trends and regional growth opportunities. Auna Analyst and Investor Day Transcript
- Neutral Sentiment: Analysts cited a consensus price target of $6.97, implying potential upside from the recent trading level, although target prices are estimates rather than guarantees. Auna Consensus Target Price
- Negative Sentiment: Auna lowered its 2026 EBITDA outlook because of contract-related pressure in Colombia. The reduction raises concerns about near-term profitability and margins even though revenue guidance was maintained. Auna Cuts 2026 EBITDA Outlook
About Auna
Auna SA is a Latin American healthcare company that provides integrated medical services through a network of hospitals, clinics, outpatient centers and specialized care facilities. Its operations include hospital care, ambulatory services, diagnostic testing, oncology treatment, preventive care and other medical specialties.
The company also offers healthcare plans and programs designed to provide access to medical services, including specialized oncology coverage. Auna’s business model combines healthcare financing and service delivery, allowing it to serve patients across different stages of care, from prevention and diagnosis to treatment and follow-up.
Auna is headquartered in Peru and serves markets in Latin America, including Peru, Colombia and Mexico.
Further Reading
- Five stocks we like better than Auna
- Newmont’s Record Quarter Shows Why Gold’s Floor Is the Real Story
- Albemarle Upgrade: Can Energy Storage Recharge Lithium’s Leader?
- Consumer Staples Are Up 12% This Year—These 3 Beverage Stocks Are Leading the Way
- Can Planet Fitness Get Its Growth Back in Shape?
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
